Darren R Brenner
Overview
Explore the profile of Darren R Brenner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
231
Citations
3031
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Basmadjian R, Xu Y, Quan M, Lupichuk S, Cheung W, Brenner D
Breast Cancer Res Treat
. 2025 Mar;
PMID: 40072699
Introduction: Outcome prediction research in early-onset breast cancer (EoBC) is limited. This study evaluated the predictive performance of NHS PREDICT v2.1 and developed two prediction models for 5-year and 10-year...
2.
Warkentin M, Murray J, Ruan Y, Graff K, Tremblay A, Brenner D
Cancer Epidemiol
. 2025 Feb;
95:102774.
PMID: 39983276
Background: Lung cancer incidence has historically been higher in males than females, but these rates have been converging. Here we detail the trends in age-specific lung cancer incidence in Canada...
3.
Banik K, Ruan Y, Stephen M, Hutchinson J, Carbonell C, Warkentin M, et al.
Cancer Control
. 2025 Feb;
32:10732748251319485.
PMID: 39943836
Introduction: The United States of America reignited their Cancer Moonshot Initiative in 2022 with an ambitious goal to reduce cancer mortality by 50% over the next 25 years. In this...
4.
Sabrie N, Minhas G, Vaska M, Meng Z, Brenner D, Forbes N
Pancreas
. 2025 Feb;
PMID: 39933053
Objectives: Pancreatitis is common following endoscopic retrograde cholangiopancreatography (ERCP). Despite increased vigilance of post-ERCP pancreatitis (PEP), both its incidence and associated mortality are rising. Risk prediction models may provide more...
5.
Warkentin M, Tammemagi M, Vakil E, Bedard E, Cheung W, Brenner D, et al.
J Thorac Oncol
. 2025 Jan;
PMID: 39743140
Introduction: Older individuals have an elevated lung cancer risk but may also have substantial comorbidities that preclude curative treatment options and limit the survival benefits of screening. The objective of...
6.
Carbonell C, Hutchinson J, Hilsden R, Yang H, Brenner D
Cancer Control
. 2024 Dec;
31:10732748241307360.
PMID: 39637415
Screening and early detection is one of the most effective approaches to reduce the population-level impact of cancer. Novel approaches to screening such as multi-cancer early detection tests (MCEDs) may...
7.
Sutherland R, OSullivan D, Ruan Y, Chow K, Mah B, Kim D, et al.
Cancers (Basel)
. 2024 Nov;
16(22).
PMID: 39594779
Background/objectives: Risk prediction models (RPMs) for colorectal cancer (CRC) could facilitate risk-based screening. Models incorporating biomarkers may improve the utility of current RPMs. We performed a systematic review of studies...
8.
Henning J, Boyne D, Brenner D, Carbonell C, Shokar S, Granados D, et al.
Clin Breast Cancer
. 2024 Nov;
PMID: 39547858
Background: Data are needed to improve the current understanding of the epidemiology of patients with high-risk, HER2-negative, early breast cancer (eBC) (hormone receptor positive [HR+]/HER2-negative BC and triple-negative BC [TNBC])....
9.
Bishay K, Meng Z, Khan R, Gupta M, Ruan Y, Vaska M, et al.
Gastroenterology
. 2024 Nov;
168(3):568-586.
PMID: 39515394
Background & Aims: Endoscopic retrograde cholangiopancreatography (ERCP)-related adverse events (AEs) are associated with morbidity, mortality, and health care expenditure. We aimed to assess incidences and comparisons of ERCP AEs. Methods:...
10.
Bishay K, Ruan Y, Barkun A, Chen Y, Singh A, Hookey L, et al.
Am J Gastroenterol
. 2024 Nov;
119(11):2317-2325.
PMID: 39495582
Introduction: Clinically significant post-endoscopic retrograde cholangiopancreatography (ERCP) bleeding (CSPEB) is common. Contemporary estimates of risk are lacking. We aimed to identify risk factors of and outcomes after CSPEB. Methods: We...